INS and diabetes mellitus: Ideally, intelligent CGM devices could be linked to an insulin delivery pump to form an artificial pancreas [12], and the benefit of CGM point-of-care tests for the self-management of diabetes patients is the reduced time length spent in hypoglycemia and the increased time in euglycemia [13,14,15].